Insider Selling: MiMedx Group (NASDAQ:MDXG) Insider Sells $432,586.00 in Stock

MiMedx Group, Inc (NASDAQ:MDXG) insider Kimberly Maersk-Moller sold 58,300 shares of the firm’s stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $7.42, for a total value of $432,586.00. Following the transaction, the insider owned 236,982 shares of the company’s stock, valued at $1,758,406.44. This trade represents a 19.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

MiMedx Group Stock Down 0.8%

MiMedx Group stock opened at $7.48 on Thursday. The firm has a market cap of $1.11 billion, a price-to-earnings ratio of 27.70 and a beta of 1.70. MiMedx Group, Inc has a 52-week low of $5.79 and a 52-week high of $10.14. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.90 and a current ratio of 4.39. The firm has a 50 day moving average price of $7.06 and a two-hundred day moving average price of $6.83.

MiMedx Group (NASDAQ:MDXG) last posted its quarterly earnings data on Monday, November 13th. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $67.69 million for the quarter. MiMedx Group had a return on equity of 28.35% and a net margin of 10.38%. Equities analysts predict that MiMedx Group, Inc will post 0.3 EPS for the current year.

Institutional Investors Weigh In On MiMedx Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. CWM LLC lifted its stake in shares of MiMedx Group by 63.8% during the 2nd quarter. CWM LLC now owns 4,857 shares of the company’s stock valued at $30,000 after buying an additional 1,892 shares in the last quarter. Virtus Advisers LLC purchased a new stake in shares of MiMedx Group during the first quarter worth $40,000. PNC Financial Services Group Inc. boosted its holdings in shares of MiMedx Group by 1,808.4% in the second quarter. PNC Financial Services Group Inc. now owns 7,500 shares of the company’s stock worth $46,000 after acquiring an additional 7,107 shares during the period. State of Alaska Department of Revenue bought a new position in shares of MiMedx Group in the third quarter worth $54,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new position in shares of MiMedx Group in the third quarter valued at $84,000. 79.15% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on MDXG. Cantor Fitzgerald raised their price target on shares of MiMedx Group from $11.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, July 31st. Weiss Ratings restated a “hold (c)” rating on shares of MiMedx Group in a research note on Wednesday, October 8th. Finally, Wall Street Zen raised MiMedx Group from a “buy” rating to a “strong-buy” rating in a research note on Sunday, November 2nd. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.